Journal
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
Volume 14, Issue 5, Pages 571-575Publisher
W B SAUNDERS CO
DOI: 10.1053/jcan.2000.9445
Keywords
coronary artery bypass graft surgery; infarction; myocardial ischemia; nitroglycerin; pharmacology; surgery
Ask authors/readers for more resources
Objective: To evaluate the use of a high dose of nitroglycerin (NTG) for prophylaxis against myocardial ischemia and infarction in patients undergoing coronary artery bypass graft (CABG) surgery with accelerated recovery. Design: Prospective, double-blind, placebo-controlled randomized study. Setting: A university-based medical center. Participants: Forty adult patients presenting for elective CABG surgery. Interventions: Forty patients were divided into 2 blinded study groups. Twenty patients received 2 mu g/kg/min of NTG starting before induction of anesthesia and continuing for 6 hours after extubation in the intensive care unit. The placebo group (n = 20) received normal saline during this same interval. Measurements and Main Results: Hemodynamics, incidence and severity of myocardial ischemia, and myocardial infarction rates were determined. There were no differences in hemodynamic parameters between groups. The incidence of ischemia was approximately 35% in each group. Myocardial infarction (as determined by elevated creatine kinase-MB fraction, troponin I, and electrocardiogram criteria) was 10% in the placebo group and 5% in the NTG group (p = 0.234). Conclusions: This study shows a high incidence of myocardial ischemia and infarction in patients presenting for CABG surgery with an accelerated recovery management scheme. NTG was well tolerated clinically; however, it was not found to be protective against myocardial ischemia or infarction in this setting. Copyright (C) 2000 by W.B. Saunders Company.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available